A detailed history of Oak Ridge Investments LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Oak Ridge Investments LLC holds 13,417 shares of AXSM stock, worth $1.22 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
13,417
Previous 13,936 3.72%
Holding current value
$1.22 Million
Previous $1.12 Million 7.49%
% of portfolio
0.1%
Previous 0.11%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$78.93 - $95.84 $40,964 - $49,740
-519 Reduced 3.72%
13,417 $1.21 Million
Q2 2024

Jul 16, 2024

SELL
$65.72 - $80.5 $131,045 - $160,517
-1,994 Reduced 12.52%
13,936 $1.12 Million
Q1 2024

May 01, 2024

BUY
$69.39 - $97.64 $28,658 - $40,325
413 Added 2.66%
15,930 $1.27 Million
Q4 2023

Jan 16, 2024

SELL
$57.42 - $83.61 $144,928 - $211,031
-2,524 Reduced 13.99%
15,517 $1.23 Million
Q3 2023

Oct 30, 2023

BUY
$69.25 - $82.21 $347,219 - $412,200
5,014 Added 38.49%
18,041 $1.26 Million
Q2 2023

Aug 07, 2023

BUY
$58.41 - $90.35 $760,907 - $1.18 Million
13,027 New
13,027 $936,000
Q3 2021

Nov 05, 2021

SELL
$19.91 - $68.26 $726,057 - $2.49 Million
-36,467 Closed
0 $0
Q2 2021

Jul 30, 2021

SELL
$50.63 - $73.5 $183,584 - $266,511
-3,626 Reduced 9.04%
36,467 $2.46 Million
Q1 2021

May 12, 2021

SELL
$55.91 - $81.44 $15.8 Million - $23 Million
-282,720 Reduced 87.58%
40,093 $2.27 Million
Q1 2021

May 04, 2021

BUY
$55.91 - $81.44 $15.8 Million - $23 Million
281,941 Added 689.81%
322,813 $18.3 Million
Q4 2020

Feb 03, 2021

SELL
$66.31 - $86.52 $629,016 - $820,728
-9,486 Reduced 18.84%
40,872 $3.33 Million
Q3 2020

Nov 12, 2020

BUY
$68.34 - $85.84 $949,379 - $1.19 Million
13,892 Added 38.1%
50,358 $3.59 Million
Q2 2020

Aug 05, 2020

SELL
$49.87 - $98.69 $157,738 - $312,156
-3,163 Reduced 7.98%
36,466 $3 Million
Q1 2020

May 13, 2020

BUY
$41.2 - $101.31 $1.63 Million - $4.01 Million
39,629 New
39,629 $2.33 Million

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.89B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Oak Ridge Investments LLC Portfolio

Follow Oak Ridge Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oak Ridge Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oak Ridge Investments LLC with notifications on news.